These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3903679)

  • 21. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of 8-methoxypsoralen kinetics: a relevant factor in the treatment of psoriasis by psoralen plus ultraviolet A therapy.
    Bonnot D; Béani JC; Boitard M; Reymond JL; Bériel H; Amblard P
    Photodermatol Photoimmunol Photomed; 1994 Feb; 10(1):33-7. PubMed ID: 8180098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and quantification of 8-methoxypsoralen-DNA adducts.
    Santella RM; Yang XY; DeLeo VA; Gasparro FP
    IARC Sci Publ; 1988; (89):333-40. PubMed ID: 3058601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoradiographic localization of 8-methoxypsoralen in psoriasis skin in vitro.
    Bertaux B; Dubertret L; Moreno G
    Acta Derm Venereol; 1981; 61(6):481-5. PubMed ID: 6177157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
    Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
    J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variation in 8-methoxypsoralen profiles during long-term psoralen plus ultraviolet A therapy and correlations between serum 8-methoxypsoralen levels and chromametric parameters.
    Marrakchi S; Decloquement L; Pollet P; Briand G; Loesche C; Bocquet JL; Degand P; Thomas P
    Photodermatol Photoimmunol Photomed; 1991 Oct; 8(5):206-11. PubMed ID: 1822684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between 8-methoxypsoralen and phenytoin. Consequence for PUVA therapy.
    Staberg B; Hueg B
    Acta Derm Venereol; 1985; 65(6):553-5. PubMed ID: 2420126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular aspects of extracorporeal photochemotherapy.
    Gasparro FP; Dall'Amico R; Goldminz D; Simmons E; Weingold D
    Yale J Biol Med; 1989; 62(6):579-93. PubMed ID: 2700057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraindividual and interindividual variability in 8-methoxypsoralen kinetics and effect in psoriatic patients.
    Herfst MJ; De Wolff FA
    Clin Pharmacol Ther; 1983 Jul; 34(1):117-24. PubMed ID: 6861433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis.
    Calzavara-Pinton P; Ortel B; Carlino A; Honigsmann H; De Panfilis G
    Exp Dermatol; 1992 Jul; 1(1):46-51. PubMed ID: 1344660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
    Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata.
    Behrens-Williams SC; Leiter U; Schiener R; Weidmann M; Peter RU; Kerscher M
    J Am Acad Dermatol; 2001 Feb; 44(2):248-52. PubMed ID: 11174382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (Meladinine) in local PUVA therapy.
    Shephard SE; Schregenberger N; Dummer R; Panizzon RG
    Dermatology; 1998; 197(1):25-30. PubMed ID: 9693181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photochemotherapy and the eye: photoprotective factors.
    Glew WB; McKeever G; Roberts WP; Malinin G; Nigra TP
    Trans Am Ophthalmol Soc; 1980; 78():243-54. PubMed ID: 7257058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical study of a new preparation of 8-methoxypsoralen in photochemotherapy.
    el-Mofty AM; el-Sawalhy H; el-Mofty M
    Int J Dermatol; 1994 Aug; 33(8):588-92. PubMed ID: 7960360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psoralen cream plus ultraviolet A photochemotherapy (PUVA cream): our experience.
    Pozo-Román T; González-López A; Velasco-Vaquero ME; Núñez-Cabezón M
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):136-42. PubMed ID: 16441619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Methoxy psoralen, etretinate, and UVA for psoriasis.
    Lane-Brown M
    Int J Dermatol; 1987 Dec; 26(10):655-9. PubMed ID: 3429102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 8-Methoxypsoralen serum levels in poor responders to photochemotherapy. Importance of drug formulation and individual factors.
    Walther T; Haustein UF
    Int J Dermatol; 1991 Jul; 30(7):516-8. PubMed ID: 1769779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absorption, distribution, and excretion of 8-methoxypsoralen in HRA/Skh mice.
    Muni IA; Schneider FH; Olsson TA; King M
    Natl Cancer Inst Monogr; 1984 Dec; 66():85-90. PubMed ID: 6531044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 8-Methoxypsoralen-DNA adducts in patients treated with 8-methoxypsoralen and ultraviolet A light.
    Yang XY; Gasparro FP; DeLeo VA; Santella RM
    J Invest Dermatol; 1989 Jan; 92(1):59-63. PubMed ID: 2642513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.